Safe Orthopaedics SA (EPA:ALSAF)
France · Delayed Price · Currency is EUR 0.6400
0.00 (0.00%)
Jun 30, 2026, 5:18 PM CET
Safe Orthopaedics Revenue
In the year 2025, Safe Orthopaedics had annual revenue of 5.36M EUR with 6.41% growth. Safe Orthopaedics had revenue of 2.84M in the half year ending December 31, 2025, a decrease of -45.36%.
Revenue
5.36M
Revenue Growth
+6.41%
P/S Ratio
0.02
Revenue / Employee
61.66K
Employees
87
Market Cap
127.51K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.36M | 323.00K | 6.41% |
| Dec 31, 2024 | 5.04M | -769.00K | -13.24% |
| Dec 31, 2023 | 5.81M | -51.00K | -0.87% |
| Dec 31, 2022 | 5.86M | 1.31M | 28.81% |
| Dec 31, 2021 | 4.55M | 439.00K | 10.68% |
| Dec 31, 2020 | 4.11M | -490.00K | -10.65% |
| Dec 31, 2019 | 4.60M | 496.00K | 12.08% |
| Dec 31, 2018 | 4.11M | 1.12M | 37.61% |
| Dec 31, 2017 | 2.98M | 397.00K | 15.35% |
| Dec 31, 2016 | 2.59M | -708.00K | -21.49% |
| Dec 31, 2015 | 3.29M | 699.00K | 26.94% |
| Dec 31, 2014 | 2.60M | 1.16M | 81.34% |
| Dec 31, 2013 | 1.43M | 733.00K | 105.01% |
| Dec 31, 2012 | 698.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.92B |
| EssilorLuxottica Société anonyme | 29.29B |
| Ipsen | 4.29B |
| Sartorius Stedim Biotech | 3.01B |
| Spineway | 12.96M |
| Bluelinea Société Anonyme | 11.12M |
| IntegraGen | 5.02M |
| bonyf | 309.37K |